Farmakokinetikken, effekten og sikkerheden af amprenavir er ikke undersøgt hos patienter over 65 år (se afsnit 5. 2).
Elderly: the pharmacokinetics, efficacy and safety of amprenavir have not been studied in patients over 65 years of age (see section 5.2).